Examination of the Effects of Long Pepper Extract on Blood Flow and Skin Surface Temperature Following the Exposure to Cold Water Stress: Placebo controlled, Randomized, Double-blind, Cross-over Study

Not Applicable

• Conditions: /A (healthy adults)

• Registration Number: JPRN-UMIN000021687
• Lead Sponsor: TES Holdings Co., Ltd

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-03-30
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Not provided

Exclusion Criteria

[1]Individuals using medical products [2]Individuals who used a drug to treat a disease in the past 1 month (except temporal usage for pollenosis) [3]Individuals who use a drug to treat a disease [4]Individuals who were an asthmatic patient in the past 3 months or is an asthmatic patient [5]Individuals with serious anemia [6]Individuals who are sensitive to a test product or other foods, and medical products [7]Individuals who had a habit to ingest health-promoting foods, foods for specified health uses, health foods, or supplyments in the past 3 months or will ingest those foods during the test period [8]Individuals with serious diseases (ex. diabetes, hepatopathy disease, kidney damage, heat failure, endocrine disease), or who is a patient of or have a history of thyroid disease, adrenal disease, metabolic disease) [9]Individuals who conducted hormone replacement therapy in the past 3 months or have a history of conducting hormone replacement therapy [10]Individuals who have an inflammation or a scar on a measuring area [11]Individuals whose systolic blood pressure is over 160mmHg or diastolic pressure is over 100mmHg [12]Individuals who excessively take alcohol (expressed in an amount of alcohol: over 60mg/day) [13]Individuals who donated blood over 200mL in the past 1 month or over 400mL in the past 3 months [14]Individuals who is a smoker [15]Individuals who participated in other clinical studies in the past 3 months [16]Individuals whose AMS scale is over 37 (male) [17]Individuals whose SMI score is over 51 (female) [18]Individuals who have a history of ovarian resection or hysterectomy (female) [19]Individuals whose prospected date of the ovulation is 2 days before or after the observation day (female) [20]Individuals who are or are posslibly, or are lactating (female) [21]Individuals judged inappropriate for the study by the principal

Study & Design

• Study Type: Interventional
• Study Design: Not specified